FIRST AMENDMENT TO SECURED CONVERTIBLE DRAWDOWN PROMISSORY NOTESecured Convertible Drawdown Promissory Note • November 14th, 2013 • Wound Management Technologies, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Texas
Contract Type FiledNovember 14th, 2013 Company Industry JurisdictionThis First Amendment to Secured Convertible Drawdown Promissory Note (this “Amendment”), dated as of November 8, 2013, is by and between Wound Management Technologies, Inc., a Texas corporation (“WTI”), Wound Care Innovations, LLC, a Nevada limited liability company (“WCI”), Resorbable Orthopedic Products, LLC, a Texas limited liability company (“ROP”), BioPharma Management Technologies, Inc., a Texas corporation (“BMT”), and Brookhaven Medical, Inc., a Delaware corporation (“Lender”). Capitalized terms used herein but not defined herein shall have the respective meanings ascribed to them in the Agreement (as defined below).
FIRST AMENDMENT TO DRAWDOWN LOAN AGREEMENTDrawdown Loan Agreement • November 14th, 2013 • Wound Management Technologies, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Texas
Contract Type FiledNovember 14th, 2013 Company Industry JurisdictionThis First Amendment to Drawdown Loan Agreement (this “Amendment”), dated as of November 8, 2013, is by and between Wound Management Technologies, Inc., a Texas corporation (“WTI”), Wound Care Innovations, LLC, a Nevada limited liability company (“WCI”), Resorbable Orthopedic Products, LLC, a Texas limited liability company (“ROP”), BioPharma Management Technologies, Inc., a Texas corporation (“BMT”), and Brookhaven Medical, Inc., a Delaware corporation (“Lender”). Capitalized terms used herein but not defined herein shall have the respective meanings ascribed to them in the Agreement (as defined below).
FIRST AMENDMENT TO LETTERLetter • November 14th, 2013 • Wound Management Technologies, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Texas
Contract Type FiledNovember 14th, 2013 Company Industry JurisdictionThis First Amendment to Letter (this “Amendment”), dated as of November 8, 2013, is by and between Brookhaven Medical, Inc. (“BMI”) and Wound Management Technologies, Inc. (the “Company”). Capitalized terms used herein but not defined herein shall have the respective meanings ascribed to them in the Letter (as defined below).